BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND CDK4, PSK-J3, 1019, ENSG00000135446, MGC14458, CMM3, P11802 AND Prognosis
45 results:

  • 1. A real-world analysis of trametinib in combination with hydroxychloroquine or cdk4/6 inhibitor as third- or later-line therapy in metastatic pancreatic adenocarcinoma.
    Tang H; Ge Y; You T; Li X; Wang Y; Cheng Y; Bai C
    BMC Cancer; 2023 Oct; 23(1):958. PubMed ID: 37817078
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Molecular and Functional Heterogeneity of Primary Pancreatic Neuroendocrine Tumors and Metastases.
    Guo Y; Tian C; Cheng Z; Chen R; Li Y; Su F; Shi Y; Tan H
    Neuroendocrinology; 2023; 113(9):943-956. PubMed ID: 37232011
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A Clinicopathological Analysis of Asian Patients with Adrenocortical Carcinoma: A Single-Center Experience.
    Tsai WH; Dai SH; Lee CC; Chien MN; Zeng YH
    Curr Oncol; 2023 Apr; 30(4):4117-4125. PubMed ID: 37185426
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Arguments for centralization of surgical treatment of ovarian cancer in France based on morbidity and mortality data].
    Meurette J; Daraï E; Tajahmady A; Fouard A; Ducastel A; Collin-Bund V; Jochum F; Lecointre L; Querleu D; Akladios C
    Bull Cancer; 2024 Mar; 111(3):239-247. PubMed ID: 36797128
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Proteogenomic insights into the biology and treatment of pancreatic ductal adenocarcinoma.
    Tong Y; Sun M; Chen L; Wang Y; Li Y; Li L; Zhang X; Cai Y; Qie J; Pang Y; Xu Z; Zhao J; Zhang X; Liu Y; Tian S; Qin Z; Feng J; Zhang F; Zhu J; Xu Y; Lou W; Ji Y; Zhao J; He F; Hou Y; Ding C
    J Hematol Oncol; 2022 Nov; 15(1):168. PubMed ID: 36434634
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Exploratory genomic analysis of high-grade neuroendocrine neoplasms across diverse primary sites.
    Sun TY; Zhao L; Van Hummelen P; Martin B; Hornbacker K; Lee H; Xia LC; Padda SK; Ji HP; Kunz P
    Endocr Relat Cancer; 2022 Dec; 29(12):665-679. PubMed ID: 36165930
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Increased trend of thyroid cancer in childhood over the last 30 years in EU countries: a call for the pediatric surgeon.
    Spinelli C; Ghionzoli M; Oreglio C; Sanna B; De Napoli L; Morganti R; Antonelli A; Morabito A; Miccoli P
    Eur J Pediatr; 2022 Nov; 181(11):3907-3913. PubMed ID: 36044066
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Blood-Based Next-Generation Sequencing in Adrenocortical Carcinoma.
    Nazha B; Zhuang TZ; Dada HI; Drusbosky LM; Brown JT; Ravindranathan D; Carthon BC; Kucuk O; Goldman J; Master VA; Bilen MA
    Oncologist; 2022 Jun; 27(6):462-468. PubMed ID: 35462410
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Implication of ERBB2 as a Predictive Tool for Survival in Patients with Pancreatic cancer in Histological Studies.
    Ortega MA; Pekarek L; Fraile-Martinez O; Garcia-Montero C; Saez MA; Asúnsolo A; Alvarez-Mon MA; Monserrat J; Ruiz-Llorente L; García-Honduvilla N; Albillos A; Buján J; Alvarez-Mon M; Guijarro LG
    Curr Oncol; 2022 Mar; 29(4):2442-2453. PubMed ID: 35448172
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The Immunological Role of cdk4/6 and Potential Mechanism Exploration in Ovarian cancer.
    Liu C; Huang Y; Cui Y; Zhou J; Qin X; Zhang L; Li X; Li Y; Guo E; Yang B; Li X; Fan J; Li X; Fu Y; Liu S; Hu D; Xiao R; Wang Z; Dou Y; Wang W; Li W; Yang X; Liu J; Peng W; Qin T; You L; Lu F; Sun C
    Front Immunol; 2021; 12():799171. PubMed ID: 35095879
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Surveillance, Epidemiology, and End Results Database update for pediatric thyroid carcinomas incidence and survival trends 2000-2016.
    Tawde A; Jeyakumar A
    Int J Pediatr Otorhinolaryngol; 2022 Feb; 153():111038. PubMed ID: 34998202
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Cisplatin Cytotoxicity in Human Testicular Germ Cell Tumor Cell Lines Is Enhanced by the cdk4/6 Inhibitor Palbociclib.
    Rossini E; Bosatta V; Abate A; Fragni M; Salvi V; Basnet RM; Zizioli D; Bosisio D; Piovani G; Valcamonico F; Mirabella G; Berruti A; Memo M; Sigala S
    Clin Genitourin Cancer; 2021 Aug; 19(4):316-324. PubMed ID: 33676835
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. LACTB mRNA expression is increased in pancreatic adenocarcinoma and high expression indicates a poor prognosis.
    Xie J; Peng Y; Chen X; Li Q; Jian B; Wen Z; Liu S
    PLoS One; 2021; 16(1):e0245908. PubMed ID: 33507917
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. A first-in-class cdk4 inhibitor demonstrates in vitro, ex-vivo and in vivo efficacy against ovarian cancer.
    Bantie L; Tadesse S; Likisa J; Yu M; Noll B; Heinemann G; Lokman NA; Ricciardelli C; Oehler MK; Beck A; Pradhan R; Milne R; Albrecht H; Wang S
    Gynecol Oncol; 2020 Dec; 159(3):827-838. PubMed ID: 32958271
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Knockdown of ribosomal protein S6 suppresses proliferation, migration, and invasion in epithelial ovarian cancer.
    Yang X; Xu L; Yang YE; Xiong C; Yu J; Wang Y; Lin Y
    J Ovarian Res; 2020 Aug; 13(1):100. PubMed ID: 32862831
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Hsa_circ_0009910: oncogenic circular RNA targets microRNA-145 in ovarian cancer cells.
    Li Y; Lin S; An N
    Cell Cycle; 2020 Aug; 19(15):1857-1868. PubMed ID: 32588730
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Clinical Characteristics and Mutation Analyses of Ovarian Sertoli-Leydig Cell Tumors.
    Yuan Z; Huo X; Jiang D; Yu M; Cao D; Wu H; Shen K; Yang J; Zhang Y; Zhou H; Wang Y
    Oncologist; 2020 Sep; 25(9):e1396-e1405. PubMed ID: 32557933
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Targeted Gene Expression Profile Reveals cdk4 as Therapeutic Target for Selected Patients With Adrenocortical Carcinoma.
    Liang R; Weigand I; Lippert J; Kircher S; Altieri B; Steinhauer S; Hantel C; Rost S; Rosenwald A; Kroiss M; Fassnacht M; Sbiera S; Ronchi CL
    Front Endocrinol (Lausanne); 2020; 11():219. PubMed ID: 32373071
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Overall survival in patients over 40 years old with surgically resected pancreatic carcinoma: a SEER-based nomogram analysis.
    Li J; Liu L
    BMC Cancer; 2019 Jul; 19(1):726. PubMed ID: 31337369
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Palbociclib, a selective cdk4/6 inhibitor, restricts cell survival and epithelial-mesenchymal transition in Panc-1 and MiaPaCa-2 pancreatic cancer cells.
    Rencuzogulları O; Yerlikaya PO; Gürkan AÇ; Arısan ED; Telci D
    J Cell Biochem; 2020 Jan; 121(1):508-523. PubMed ID: 31264276
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.